How to Know If Your Liver Is Healthy: Tests, Ultrasound, FibroScan & Warning Signs

By Dr. Karan R. Rawat
Patient Education | Liver & Digestive Health

SEO Title: How to Check Your Liver Health: LFT, Ultrasound, FibroScan & Important Tests
Meta Description: Want to know whether your liver is healthy? Learn which blood tests, LFT, ultrasound, FibroScan, hepatitis tests and fibrosis assessments can help evaluate liver health—and when you should see a specialist.

Your Liver Can Be Unhealthy Even When You Feel Completely Fine

The liver is one of the most important organs in the human body. It helps process nutrients, metabolise medicines, produce proteins, regulate blood clotting, store energy, process bilirubin and remove many substances from the bloodstream.

The problem is that early liver disease is often silent.

Fatty liver disease, chronic viral hepatitis and even significant liver fibrosis may cause few or no symptoms in their early stages. Therefore, waiting for jaundice or abdominal swelling before checking the liver may mean waiting until disease has become advanced.

So, if you ask:

“Doctor, how can I know whether my liver is healthy?”

The answer is not one single test.

A meaningful liver assessment usually considers:

Blood tests + risk factors + imaging + fibrosis assessment when indicated.

1. Start With Liver Function Tests — But Understand What They Actually Tell You

The commonly ordered Liver Function Test, or LFT, usually includes several measurements.

Interestingly, not every component of an LFT actually measures liver “function.” Some mainly indicate liver-cell injury or obstruction, while others provide information about how well the liver is performing its synthetic functions.

ALT – Alanine Aminotransferase

ALT is found predominantly in liver cells.

An elevated ALT may occur with conditions such as:

  • metabolic dysfunction-associated steatotic liver disease, or MASLD—the modern term commonly used for metabolic fatty liver disease

  • viral hepatitis

  • alcohol-associated liver injury

  • drug- or supplement-related liver injury

  • autoimmune hepatitis

  • other causes of liver-cell inflammation

An abnormal ALT tells us that liver-cell injury may be occurring, but ALT alone cannot determine the exact cause or severity.

AST – Aspartate Aminotransferase

AST is another enzyme commonly measured with ALT.

It can rise due to liver disease, although AST is also present in muscles and other tissues. Therefore, AST should usually be interpreted together with ALT and the rest of the clinical picture.

ALP – Alkaline Phosphatase

A disproportionately raised ALP can suggest a problem involving the bile ducts or bile flow.

However, ALP can also come from bone, so an abnormal result needs appropriate interpretation.

GGT – Gamma-Glutamyl Transferase

GGT can help determine whether an elevated ALP is likely to be related to the liver or biliary system.

It may also rise with alcohol exposure, fatty liver, medicines and several other conditions. GGT should therefore not be interpreted in isolation.

Bilirubin

Bilirubin is processed by the liver and excreted through bile.

High bilirubin may occur with:

  • hepatitis

  • bile duct obstruction

  • advanced liver dysfunction

  • increased breakdown of red blood cells

  • several inherited or benign conditions

A patient with significantly elevated bilirubin may develop yellowing of the eyes or skin—jaundice.

Albumin

Albumin is an important protein produced by the liver.

A low albumin level can occur in advanced chronic liver disease, although kidney disease, malnutrition, inflammation and several other illnesses can also lower albumin.

Blood tests including ALT, AST, alkaline phosphatase, bilirubin and albumin are commonly used during the evaluation of chronic liver disease and cirrhosis.

2. Do Not Make This Common Mistake: “My LFT Is Normal, So My Liver Must Be Normal”

Not necessarily.

This is one of the most important points in liver health.

A person can have fatty liver or even significant fibrosis despite having aminotransferase levels within the laboratory reference range.

Research in people with fatty liver disease has demonstrated that advanced fibrosis and cirrhosis can occur even when aminotransferase levels are normal.

Therefore:

Normal ALT and AST are reassuring, but they do not provide a complete guarantee that there is no significant liver disease.

This becomes especially important in people with diabetes, obesity, increased waist circumference, high triglycerides, metabolic syndrome, significant alcohol exposure or other liver-disease risk factors.

3. CBC and Platelet Count Can Also Tell Us Something About the Liver

A Complete Blood Count, or CBC, is frequently useful during liver assessment.

One particularly important value is the platelet count.

A low platelet count can sometimes be an early clue to portal hypertension or advanced chronic liver disease, although many other conditions can also cause low platelets.

Platelet count is also used along with age, AST and ALT to calculate the FIB-4 score, an important non-invasive tool used to estimate the likelihood of significant liver fibrosis.

4. PT/INR Helps Assess the Liver’s Ability to Produce Clotting Proteins

The liver produces several proteins required for normal blood clotting.

Therefore, Prothrombin Time and INR may be checked when significant liver dysfunction is suspected.

An abnormal INR can occur in advanced liver dysfunction, although medicines such as anticoagulants, vitamin K deficiency and other conditions can also affect the result.

In patients being evaluated for significant chronic liver disease, bilirubin, albumin and INR provide particularly useful information about liver function.

5. Check Your Metabolic Health—Because Fatty Liver Is Often a Metabolic Problem

For many patients today, assessing liver health also means assessing metabolic health.

Useful investigations may include:

  • fasting blood sugar

  • HbA1c

  • lipid profile

  • triglycerides

  • blood pressure

  • body weight

  • BMI

  • waist circumference

Obesity, insulin resistance, type 2 diabetes, abnormal cholesterol and metabolic syndrome are important risk factors for metabolic fatty liver disease.

This is why a person with diabetes or obesity should not focus only on whether ALT is “normal.”

The more important question may be:

“Is there fat in my liver, and more importantly, has fibrosis or scarring started?”

6. Ultrasound Abdomen: What Can It Tell You?

An ultrasound of the abdomen is one of the most commonly used imaging investigations for the liver.

It can provide information about:

  • liver size

  • liver texture

  • fatty changes

  • some signs of chronic liver disease

  • gallbladder stones

  • bile duct dilatation

  • some liver masses

  • fluid in the abdomen

  • spleen enlargement

Ultrasound can detect liver fat in many patients, but a routine ultrasound cannot reliably determine whether fatty liver has progressed to inflammation or accurately stage fibrosis.

Therefore:

“Fatty liver Grade 1 on ultrasound” is not the complete assessment of liver health.

The more important long-term question is whether significant fibrosis is present.

7. FibroScan: Looking Beyond Fatty Liver to Liver Stiffness

A FibroScan, technically known as vibration-controlled transient elastography, is a non-invasive test that can measure liver stiffness.

Greater liver stiffness may indicate fibrosis or scarring.

Many FibroScan systems can also provide an estimate of liver fat through a measurement known as CAP—Controlled Attenuation Parameter.

Elastography is increasingly used to assess patients who may be at risk of significant liver fibrosis without immediately resorting to liver biopsy. NIDDK and AASLD guidance recognise elastography as an important non-invasive method of evaluating liver fibrosis.

FibroScan can be particularly useful in selected patients with:

  • fatty liver

  • obesity

  • diabetes

  • metabolic syndrome

  • chronic hepatitis B or C

  • significant alcohol exposure

  • persistently abnormal liver enzymes

  • suspected chronic liver disease

It should still be interpreted along with clinical history, laboratory results and other investigations.

8. What Is the FIB-4 Score?

The FIB-4 score is calculated using:

Age + AST + ALT + Platelet Count

It is inexpensive because it uses information from routine blood investigations.

FIB-4 is commonly used as a first-line non-invasive assessment of fibrosis risk, particularly in people with metabolic fatty liver disease. Patients whose results suggest higher or uncertain risk may subsequently undergo elastography such as FibroScan or another fibrosis assessment.

One important caution:

FIB-4 is a risk-stratification tool—not a diagnosis of cirrhosis.

Age and clinical circumstances influence its interpretation, so simply entering the numbers into an online calculator without medical interpretation can be misleading.

9. Should You Test for Hepatitis B and Hepatitis C?

Yes, in appropriate patients, viral hepatitis testing is an important part of liver-health assessment.

Chronic hepatitis B and hepatitis C may remain asymptomatic for years, while progressive liver fibrosis develops.

Tests may include:

Hepatitis B

Depending on the clinical purpose:

  • HBsAg

  • anti-HBs

  • total anti-HBc

  • additional HBV tests if screening is abnormal

International guidance such as the CDC recommends at least one lifetime hepatitis B screening using a three-test panel for adults, with repeat or additional testing depending on risk factors and circumstances. Screening policies should also follow applicable local guidance.

Hepatitis C

Initial screening generally involves an anti-HCV antibody test.

If reactive, confirmation with HCV RNA testing is required to establish current infection.

CDC guidance recommends at least one lifetime hepatitis C screening for most adults, with periodic testing in people who have continuing exposure risk.

10. Do You Need an AFP or “Liver Cancer Test” as Part of Every Liver Check-Up?

Usually, no.

AFP is not a general liver-health screening test for everyone.

Liver-cancer surveillance is mainly relevant to defined higher-risk groups, particularly selected patients with cirrhosis or chronic hepatitis B.

Therefore, ordering multiple tumour markers as part of a generic “liver package” without clinical indication is not necessarily useful.

Investigations should answer a clinical question—not simply increase the number of tests on the prescription.

11. When Are Special Liver Tests Required?

If routine evaluation suggests liver disease, a doctor may occasionally request additional tests depending on the suspected cause.

Examples include tests for:

  • autoimmune hepatitis

  • iron overload

  • Wilson disease

  • primary biliary cholangitis

  • other metabolic or genetic liver diseases

Autoimmune hepatitis, for example, may require assessment with antibodies such as ANA and SMA along with immunoglobulin levels and other investigations. No single blood test can diagnose every liver condition.

These specialised tests are not required for every healthy person.

A Practical Liver Health Assessment

For many adults, liver assessment can be thought of in stages.

Assessment What It Helps Evaluate
ALT, AST Liver-cell injury
ALP, GGT Bile-duct/cholestatic pattern
Bilirubin Bilirubin processing and excretion
Albumin Liver synthetic function, interpreted with other conditions
PT/INR Clotting-factor production in appropriate settings
CBC & Platelets Anaemia, platelets and clues to advanced liver disease
HbA1c / Blood Sugar Diabetes and metabolic risk
Lipid Profile Cholesterol and triglyceride-related metabolic risk
Hepatitis B & C tests Chronic viral hepatitis
Ultrasound Abdomen Liver structure, fatty change and associated abnormalities
FIB-4 Non-invasive fibrosis-risk estimation
FibroScan / Elastography Liver stiffness and fibrosis assessment
Special liver tests Used when a particular disease is suspected

The correct combination depends on the patient's age, symptoms, medical history and risk factors.

Who Should Pay Particular Attention to Liver Health?

Consider discussing liver assessment with your doctor if you have:

  • overweight or obesity

  • increased waist circumference

  • diabetes or prediabetes

  • high triglycerides or abnormal cholesterol

  • high blood pressure

  • known fatty liver

  • regular or heavy alcohol intake

  • previous abnormal LFT

  • hepatitis B or C risk

  • family history of liver disease

  • prolonged use of medicines capable of affecting the liver

  • use of unregulated herbal or bodybuilding supplements

  • persistent unexplained fatigue or appetite loss

  • jaundice

People with metabolic risk factors deserve particular attention because fatty liver disease can progress from fat accumulation to inflammation, fibrosis and, in some patients, cirrhosis.

Warning Signs You Should Not Ignore

Seek medical assessment promptly if you develop:

  • yellow eyes or skin

  • very dark urine with jaundice

  • increasing abdominal swelling

  • swelling of the feet

  • vomiting blood

  • black stools

  • unexplained significant weight loss

  • persistent severe itching with jaundice

  • easy bleeding or bruising

  • increasing sleepiness, confusion or altered behaviour

  • severe abdominal pain with fever or jaundice

Symptoms of advanced cirrhosis may not appear until substantial liver damage has already occurred.

“Doctor, Just Tell Me the Best Test for Liver Health”

There is no single best liver test.

If we check only ALT and AST, we may miss fibrosis.

If we perform only ultrasound, we may identify fat but not accurately determine the amount of liver scarring.

If we perform only FibroScan without understanding the patient's history and blood tests, the result may also be misinterpreted.

A better approach is:

1. Identify your risk factors
2. Check appropriate blood investigations
3. Look for metabolic and viral causes
4. Use ultrasound when clinically indicated
5. Assess fibrosis risk with FIB-4 and/or elastography in appropriate patients
6. Investigate the underlying cause if abnormalities are found

Can Fatty Liver Be Reversed?

In many patients, especially during earlier stages, improvement in metabolic health can substantially reduce liver fat.

Management may involve:

  • weight reduction when overweight

  • regular physical activity

  • better diabetes control

  • control of triglycerides and cholesterol

  • avoiding excessive alcohol

  • reviewing unnecessary medicines or supplements

  • treatment of the underlying liver disease

However, the objective should not merely be to make the ultrasound report say “fatty liver reduced.”

The major long-term concern is preventing progression to fibrosis and cirrhosis.

Frequently Asked Questions

My LFT is normal. Do I still need an ultrasound?

Not everyone with normal LFT needs an ultrasound. However, normal liver enzymes do not completely exclude fatty liver or fibrosis. Whether imaging is appropriate depends on your symptoms and risk factors.

I have Grade 1 fatty liver. Should I worry?

Grade 1 fatty liver on ultrasound does not automatically mean severe liver disease. The next question is whether you have metabolic risk factors or evidence of liver fibrosis.

Which is better—ultrasound or FibroScan?

They answer different questions. Ultrasound mainly examines liver structure and can detect fatty changes. FibroScan is designed primarily to assess liver stiffness and estimate fibrosis and may also estimate steatosis.

Can a blood test detect liver fibrosis?

Blood-test-based scores such as FIB-4 can estimate the probability of significant fibrosis. They are usually used for risk stratification rather than as a stand-alone diagnosis.

Do I need a liver biopsy?

Most people undergoing a routine liver evaluation do not need one. Biopsy may be considered when the diagnosis remains uncertain, when specific liver diseases require confirmation, or when non-invasive tests do not provide enough information.

How often should I check my liver?

There is no single interval suitable for everyone. Frequency depends on your age, alcohol intake, weight, diabetes, metabolic risk, medicines, viral-hepatitis status and previous test results.

The Take-Home Message

Liver health is more than an LFT report.

A sensible assessment asks four important questions:

Is the liver being injured?
Look at enzymes such as ALT and AST.

Is the liver functioning properly?
Consider bilirubin, albumin and, when appropriate, PT/INR.

Is there fat or a structural abnormality?
Ultrasound can help.

Has liver fibrosis or scarring developed?
FIB-4 and elastography such as FibroScan may help identify patients who require further evaluation.

And perhaps the most important message:

Do not wait for jaundice to start thinking about your liver.

Early identification of fatty liver, viral hepatitis and liver fibrosis provides an opportunity to address the cause before advanced liver damage develops.

About Dr. Karan R. Rawat

Dr. Karan R. Rawat provides evaluation and treatment for liver, gallbladder, pancreatic and gastrointestinal conditions, including fatty liver, abnormal liver-function tests, jaundice, hepatitis and chronic liver disease.

Consultation: Safe Gastro & Surgery Center, Agra Heart Center, Church Road, Civil Lines, Agra
Appointment: 7398888889

Patients with persistent abnormal liver tests, fatty liver, jaundice or suspected chronic liver disease should undergo an individualised assessment rather than relying solely on a pre-designed “liver health package.”

This article is intended for patient education and does not replace an individual medical consultation. Tests should be selected according to the patient's history, examination, symptoms and risk factors.

Evidence reviewed: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), American Association for the Study of Liver Diseases (AASLD), and Centers for Disease Control and Prevention (CDC).